The influence of phytic acid on TNF-α and its receptors genes' expression in colon cancer Caco-2 cells

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 1, 2008, Pages 75-79

  Cholewa, Krzysztof ^a   Parfiniewicz, Beata ^a   Bednarek, Ilona ^a   Świa̧tkowska, Longina ^a   Jezienicka, Ewa ^a   Kierot, Jolanta ^a   Wȩglarz, Ludmiła ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Caco 2 cells; Phytic acid; QRT PCR; TNF ; TNFRI; TNFRII

Indexed keywords

PHYTIC ACID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN CACO 2; COLON CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CACO-2 CELLS; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHYTIC ACID; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 42549139289     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Harland B.F., Oberleas D.: World Rev. Nutr. Diet. 52, 235 (1987).
2. Vucenik I., Ramakrishna G., Tantivejkul K., Anderson L.M., Ramljak D.: Breast Cancer Res. Treat. 91, 35 (2005).
3. Shamsuddin A.M.: Int. J. Food Sci. Technol. 37, 769 (2002).
4. Vucenik I., Shamsuddin A.M.: J. Nutr. 133, 3778S (2003).
5. Vucenik I., Shamsuddin A.M.: Nutr. Cancer 55, 109 (2006).
6. Tian Y., Song Y.: World J. Gastroenterol. 12, 4137 (2006).
7. Shamsuddin A.M., Yang G-Y, Vucenik I.: Anticancer Res. 16, 3287 (1996).
8. Singh R.P., Agarwal C., Agarwal R.: Carcinogenesis 24, 555 (2003).
9. Dorsey M., Benhuzzi H., Tucci M., Cason Z.: Biomed Sci. Instrum. 41, 205 (2005).
10. Vucenik I., Tantivejkul K., Zhang Z.S., Cole K.E., Saied I., Shamsuddin A.M.: Anticancer Res. 18, 4083 (1998).
11. Somasundar P., Riggs D.R., Jackson B.J., Cunningham C., Vona-Davis L.: J. Surg. Res. 126, 199 (2005).
12. Rizvi I., Riggs D.R., Jackson B.J., Cunningham C., McFadden D.W.: J. Surg. Res. 133, 3, (2006).
13. Morisson R.S., Shi E., Kan M., Yamaguchi F., McKeehan W.: In vitro Cell. Dev. Biol. 30a, 783 (1994).
14. Huang C., Ma W.Y., Hecht S.S., Dong Z.: Cancer Res. 57, 2873 (1997).
15. Nickel K.P., Belury M.A.: Cancer Lett. 140, 105 (1999).
16. Vucenik I., Ramakrishna G., Tantivejkul K., Anderson L., Ramljak D.: Proc. Amer. Assoc. Cancer Res. 40, 653 (1999).
17. Solyakov L., Cain K., Tracey B.M., Jukes R., Riley A.M. et al.: J. Biol. Chem. 279, 43403 (2003).
18. Muraoka S., Miura T.: Life Sci. 74, 1691 (2004).
19. Wecombining ogonekglarz L., Molin I., Orchel A., Parfiniewicz B., Dzierżewicz Z.: Acta Biochim. Polon. 53, 349 (2006).
20. Eggleton P.: Anticancer Res.19, 3711 (1999).
21. Wecombining ogonekglarz L., Wawszczyk J., Orchel A., Jaworska-Kik M., Dzierżewicz Z.: Dig. Dis. Sci. 52, 93 (2007).
22. Zins K., Abraham D., Sioud M., Aharinejad S.: Cancer Res. 67, 1038 (2007).
23. García-Tuñón I., Ricote M., Ruiz A., Fraile B., Paniagua R., Royuela M.: Cancer Sci. 10, 1044 (2006).
24. Cherng J.M., Chiang W., Chiang L.C.: Food Chem. 104, 613 (2007).
25. Sveinbjørnsson B., Rushfeldt C., Olsen R., Smedsrød B., Seljelid R.: Biochem. Biophys. Res. Commun. 233, 270 (1997).